drugset / Trial / NCT00004480
Study of Botulinum Toxin in Patients With Primary Hyperhidrosis
Completed
Icahn School of Medicine at Mount Sinai
Treatment
Summary
OBJECTIVES: I. Determine the optimal dose of botulinum toxin necessary to decrease sweating in patients with primary hyperhidrosis.
Timeline
- Start
- 1999-07
- Primary completion
- —
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Botulinum toxin type A | Protein / enzyme biologic | — | — |